ACAR · Arterial Calcification & Arterial Regeneration ‘ACAR’
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2011-12-01 → 2014-11-30
- Финансиране от ЕС
- 75 000 €
- Участници
- 1
- Схема
- MC-CIG
Линиите свързват координатора с партньорите.
Накратко на български
Артериалните клетки се изследват, за да се разбере как се влияе на калцификацията чрез витамин К и селен. Това помага за по-доброто разбиране на процесите на възстановяване на кръвоносните съдове при пациенти с периферни артериални заболявания.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Periodic Report Summary 1 - ACAR (Arterial Calcification & Arterial Regeneration ‘ACAR’)
This project sought (i) to establish a cell culture facility in the host laboratory in Waterford Institute of Technology to support the planned research programme, (ii) to investigate and identify calcification biomarkers in vascular smooth muscle cells and the influence of vitamin K and selenium of calcification processes (iii) to investigate the regenerative capabilities of endothelial progenitor cells (EPC) by developing an EPC culture assay, culture EPC from peripheral arterial disease patients and controls, and examine biomarker expression on these EPC. A cell culture facility was established in the Biomedical Research Centre (BRC) and managed by the funded researcher, Dr. John Phelan. Considerable time was invested in establishing this facility from scratch. Cell lines were obtained and standard operating procedures developed and training delivered to other students in WIT. Interest has been shown in the facility by local industry with one potential joint venture under consideration by a parent company. The researcher also assisted in the development of a module for an MSc in Analytical Science that involves cell culture. Dr Phelan established the laboratory infrastructure for the conduct of the proposed programme of research. Ethical approval was obtained from Waterford Institute of Technology for the EPC study. During the funding period, Dr. Phelan gained considerable management experience as he co-ordinated the activities of the Biomedical Research Centre (BRC). This involved processing orders and managing accounts, managing the newly established biomedical research laboratory, liaising with medical partners in Waterford Regional Hospital and assisting with ongoing research projects. Considerable progress was made establishing Standard Operating Procedures (SOPs) for various instruments and techniques and troubleshooting experimental problems. Dr. Phelan acted as secretary to the BRC, recording meeting minutes and acting as a point of contact for the research group. He organised BRC journal clubs. He also joined the research ethics committee at the Waterford Regional Hospital. Regrettably, Dr. Phelan left WIT, for employment in the BIOMERIT Research Centre - University College Cork (UCC), before the two specific research projects identified above could be completed. Ethical approval was obtained from WIT for the endothelial progenitor cell culture study involving peripheral arterial disease patients and controls (objective iii above). In addition the culture EPC assay was established. Dr. Phelan also achieved a number of journal and conference publications during the funding period.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Arterial calcification is a morbid complication of inflammatory disease causing calcium deposition along arterial walls. Sheer stresses on cellular components affect regenerative capabilities of specific cells, culminating in vessel constriction, compromised wall elasticity and reduced blood flow. The net effect of restricted blood flow is debilitating and can cause cardiovascular disease, end stage renal disease or peripheral arterial disease. Animal models have uncovered biomarkers involved in calcification however little is known in humans. Therefore we will investigate two calcification mechanisms believed to play a role; warfarin, an anticoagulant and inducer of calcification in certain cells and oxidative stress which impacts on cellular mechanisms increasing calcification status.Firstly, we will demonstrate that stress induced calcification biomarkers are deregulated in vascular smooth muscle cells. We will identify novel biomarkers involved in this process. We will also investigate calcification reversal using vitamin K and selenium supplementation in these cells by monitoring calcification biomarker expression.Secondly, we will investigate the regenerative capabilities of endothelial progenitor cells in peripheral arterial disease, a serious inflammatory disease. From patients and controls, we will isolate endothelial progenitor cells and compare biomarker expression using cell culture assays which will be developed in the laboratory.This research project fulfils several objectives. Firstly, it facilitates reintegration of the researcher allowing him to establish cell culturing facilities in the host laboratory. Secondly, it allows for the investigation and identification of calcification biomarkers in human cells and cellular mechanisms to combat this and finally to investigate the regenerative capabilities of endothelial progenitor cells in subjects. This research could establish mechanistic paradigms implicated in other inflammatory diseases.""
Оригинален текст от CORDIS (на английски).
Участници
- WATERFORD INSTITUTE OF TECHNOLOGY · WaterfordКоординаторИрландия
Връзки
Данни: CORDIS, © Европейски съюз
